
Clearside Biomedical
A biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases.
Market cap
$61.4m
Enterprise value
$48m
Share price
$0.80 CLSD
Authorizing premium user...